Pattern of Lymph Node Involvement and Prognosis in Pancreatic Adenocarcinoma: Direct Lymph Node Invasion Has Similar Survival to Node-Negative Disease

被引:41
作者
Pai, Rish K. [4 ]
Beck, Andrew H. [1 ]
Mitchem, Jonathan [5 ]
Linehan, David C. [5 ]
Chang, Daniel T. [2 ]
Norton, Jeffrey A. [3 ]
Pai, Reetesh K. [1 ]
机构
[1] Stanford Univ, Dept Pathol, 300 Pasteur Dr,Room H-2110, Stanford, CA 94305 USA
[2] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA
[3] Stanford Univ, Dept Surg, Stanford, CA 94305 USA
[4] Washington Univ, Dept Pathol, St Louis, MO 63130 USA
[5] Washington Univ, Dept Surg, St Louis, MO 63130 USA
关键词
lymph node metastasis; pancreatic ductal adenocarcinoma; direct lymph node invasion; CANCER; CARCINOMA; PANCREATICODUODENECTOMY; RATIO; METASTASIS; MECHANISM; RESECTION; HEAD;
D O I
10.1097/PAS.0b013e318206c37a
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Lymph node status is one of the most important predictors of survival in pancreatic ductal adenocarcinoma. Surgically resected pancreatic adenocarcinoma is often locally invasive and may invade directly into peripancreatic lymph nodes. The significance of direct invasion into lymph nodes in the absence of true lymphatic metastases is unclear. The purpose of this study was to retrospectively compare clinical outcome in patients with pancreatic ductal adenocarcinoma with direct invasion into peripancreatic lymph nodes with patients with node-negative adenocarcinomas and patients with true lymphatic lymph node metastasis. A total of 380 patients with invasive pancreatic ductal adenocarcinoma classified as pT3, were evaluated: ductal adenocarcinoma with true lymphatic metastasis to regional lymph nodes (248 cases), ductal adenocarcinoma without lymph node involvement (97 cases), and ductal adenocarcinoma with regional lymph nodes involved only by direct invasion from the main tumor mass (35 cases). Isolated lymph node involvement by direct invasion occurred in 35 of 380 (9%) patients. Overall survival for patients with direct invasion of lymph nodes (median survival, 21 mo; 5-year overall survival, 36%) was not statistically different from patients with node-negative adenocarcinomas (median survival, 30 mo; 5-year overall survival, 31%) (P = 0.609). Patients with node-negative adenocarcinomas had an improved survival compared with patients with lymph node involvement by true lymphatic metastasis (median survival, 15 mo; 5-year overall survival, 8%) (P < 0.001) regardless of the number of lymph nodes involved by adenocarcinoma. There was a trend toward decreased overall survival for patients with 1 or 2 lymph nodes involved by true lymphatic metastasis compared with patients with direct invasion of tumor into lymph nodes (P = 0.056). However, this did not reach statistical significance. Our results indicate that patients with isolated direct lymph node invasion have a comparable overall survival with patients with node-negative adenocarcinomas as opposed to true lymphatic lymph node metastasis.
引用
收藏
页码:228 / 234
页数:7
相关论文
共 29 条
  • [1] The number of lymph nodes identified in a simple pancreatoduodenectomy specimen: comparison of conventional vs orange-peeling approach in pathologic assessment
    Adsay, N. Volkan
    Basturk, Olca
    Altinel, Deniz
    Khanani, Fayyaz
    Coban, Ipek
    Weaver, Donald W.
    Kooby, David A.
    Sarmiento, Juan M.
    Staley, Charles
    [J]. MODERN PATHOLOGY, 2009, 22 (01) : 107 - 112
  • [2] [Anonymous], 2007, R LANGUAGE ENV STAT
  • [3] [Anonymous], ARCH SURG
  • [4] Benassai G, 1999, J EXP CLIN CANC RES, V18, P23
  • [5] Berger AC, 2004, AM SURGEON, V70, P235
  • [6] Validation of the 6th Edition AJCC Pancreatic Cancer Staging System - Report from the National Cancer Database
    Bilimoria, Karl Y.
    Bentrem, David J.
    Ko, Clifford Y.
    Ritchey, Jamie
    Stewart, Andrew K.
    Winchester, David P.
    Talamonti, Mark S.
    [J]. CANCER, 2007, 110 (04) : 738 - 744
  • [7] Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas
    Brennan, MF
    Kattan, MW
    Klimstra, D
    Conlon, K
    [J]. ANNALS OF SURGERY, 2004, 240 (02) : 293 - 298
  • [8] Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: Treatment variables and survival duration
    Breslin, TM
    Hess, KR
    Harbison, DB
    Jean, ME
    Cleary, KR
    Dackiw, AP
    Wolff, RA
    Abbruzzese, JL
    Janjan, NA
    Crane, CIH
    Vauthey, JN
    Lee, JE
    Pisters, PWT
    Evans, DB
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2001, 8 (02) : 123 - 132
  • [9] New signals from the invasive front
    Christofori, G
    [J]. NATURE, 2006, 441 (7092) : 444 - 450
  • [10] Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005)
    Corsini, Michele M.
    Miller, Robert C.
    Haddock, Michael G.
    Donohue, John H.
    Farnell, Michael B.
    Nagorney, David M.
    Jatoi, Aminah
    McWilliams, Robert R.
    Kim, George P.
    Bhatia, Sumita
    Iott, Matthew J.
    Gunderson, Leonard L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3511 - 3516